Head to head
Kronos Worldwide vs Linde
Side-by-side on the measures that matter, with a plain-English read. Full detail: KRO · LIN
KRO
Kronos Worldwide
7.81+0.39%
1-year price shape — +48% over the period
Quant Rating B · 81/100
vs
LIN
Linde
485.29+0.27%
1-year price shape — +4% over the period
Quant Rating D · 45/100
1-year performance, rebased to 100
It’s close.
| KRO | LIN | |
|---|---|---|
| Snapshot | ||
| Sector | Specialty Chemicals | Specialty Chemicals |
| Last price | 7.81 | 485.29 |
| Change today | +0.39% | +0.27% |
| 1-year return | +48.2% | +4.3% |
| Market cap | $898.91M | $223.71B |
| 52-week range | 3.94 – 9.12 | 384.00 – 546.40 |
| Valuation | ||
| P/E (TTM) | -8.22 | 31.31 |
| P/E percentile, own 5-yr range | 30th | 8th |
| P/B | 1.20 | 5.72 |
| Dividend yield | 2.56% | 1.28% |
| Profitability & growth | ||
| EPS (TTM) | -0.96 | 14.61 |
| Net profit (TTM) | $-110.49M | $6.73B |
| Revenue (TTM) | $1.94B | $35.45B |
| Revenue growth (YoY) | +12.9% | +9.3% |
| Gross margin | 11.8% | 48.3% |
| Operating margin | -1.4% | 27.1% |
| Net margin | -5.6% | 20.4% |
| Free cash flow (TTM) | $43.30M | $4.98B |
| Ownership & sentiment | ||
| Institutional ownership | 97.3% | 88.0% |
| Insider activity (12mo) | 32 buy / 0 sell | 33 buy / 13 sell |
| Short interest (% of float) | 0.9% | 1.3% |
| Analyst consensus | 100% buy (1) | 87% buy / 13% hold (15) |
| Analyst price target | $9 (+15%) | $557 (+15%) |
| StockVane view | ||
| StockVane Quant Rating | B (81) | D (45) |
| Company | ||
| Employees | 2,263 | 65,177 |
| Founded | 1916 | 2017 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.